137 related articles for article (PubMed ID: 33063311)
21. [Clinical analysis of seven cases of rare hemolytic disease of the newborn].
Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ
Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824
[No Abstract] [Full Text] [Related]
22. Wasted health care dollars. Routine cord blood type and Coombs' testing.
Leistikow EA; Collin MF; Savastano GD; de Sierra TM; Leistikow BN
Arch Pediatr Adolesc Med; 1995 Oct; 149(10):1147-51. PubMed ID: 7550820
[TBL] [Abstract][Full Text] [Related]
23. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
24. Importance of Direct Antiglobulin Test (DAT) in Cord Blood: Causes of DAT (+) in a Cohort Study.
Valsami S; Politou M; Boutsikou Τ; Briana D; Papatesta M; Malamitsi-Puchner A
Pediatr Neonatol; 2015 Aug; 56(4):256-60. PubMed ID: 25637293
[TBL] [Abstract][Full Text] [Related]
25. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
Kumlien G; Sarman I; Shanwell A
Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
[TBL] [Abstract][Full Text] [Related]
26. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
[TBL] [Abstract][Full Text] [Related]
27. [Detection and analysis of ABO Hemolytic disease in newborn].
Lin ZX; Dong QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
[TBL] [Abstract][Full Text] [Related]
28. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
[TBL] [Abstract][Full Text] [Related]
29. The management of hemolytic disease in the fetus and newborn.
Bowman J
Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
[TBL] [Abstract][Full Text] [Related]
30. [Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women].
Yang SM; Wu QY; Luo HQ; Lan JC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):875-7. PubMed ID: 16277862
[TBL] [Abstract][Full Text] [Related]
31. [Prevention, diagnosis and treatment of blood group immunization during pregnancy].
van Aken WG; Christiaens GC
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2507-10. PubMed ID: 10627751
[TBL] [Abstract][Full Text] [Related]
32. A case of hemolytic disease of the newborn infant due to anti-K (Cellano).
Moncharmont P; Juron-Dupraz F; Doillon M; Vignal M; Debeaux P
Acta Haematol; 1991; 85(1):45-6. PubMed ID: 2011931
[TBL] [Abstract][Full Text] [Related]
33. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
34. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
Holusková I; Lubušký M; Studničková M; Procházka M
Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
[TBL] [Abstract][Full Text] [Related]
35. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
36. Laboratory identification of erythroblastosis fetalis.
Kurtz EM; Pappas AA; Cannon A
Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
[TBL] [Abstract][Full Text] [Related]
37. Interpretation of the direct antiglobulin test in neonates with haemolytic disease of the newborn.
Tuladhar R; Patole SK; Whitehall JS
Int J Clin Pract; 2000; 54(1):64. PubMed ID: 10750264
[TBL] [Abstract][Full Text] [Related]
38. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
[TBL] [Abstract][Full Text] [Related]
39. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
[TBL] [Abstract][Full Text] [Related]
40. Haemolytic disease of newborn.
Narang A; Jain N
Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
